WO2007005787A3 - Methods and compositions for keratinocyte culture and therapeutics - Google Patents
Methods and compositions for keratinocyte culture and therapeutics Download PDFInfo
- Publication number
- WO2007005787A3 WO2007005787A3 PCT/US2006/025907 US2006025907W WO2007005787A3 WO 2007005787 A3 WO2007005787 A3 WO 2007005787A3 US 2006025907 W US2006025907 W US 2006025907W WO 2007005787 A3 WO2007005787 A3 WO 2007005787A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- collagenase
- methods
- compositions
- therapeutics
- keratinocyte culture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Abstract
The invention encompasses composition and methods for cell culture and for therapeutic and cosmetic use. The compositions and methods utilize collagenase, e.g., bacterial collagenase, other isolated collagenase, or synthetic collagenase, e.g., recombinant collagenase. One form of collagenase that can be used in some embodiments of the invention is matrix metalloproteinase-1. The compositions and methods of the invention also optionally utilize a cAMP-elevating agent.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69595605P | 2005-07-01 | 2005-07-01 | |
US60/695,956 | 2005-07-01 | ||
US11/257,927 | 2005-10-24 | ||
US11/257,928 US20070003541A1 (en) | 2005-07-01 | 2005-10-24 | Methods and compositions for therapeutics |
US11/257,573 | 2005-10-24 | ||
US11/257,928 | 2005-10-24 | ||
US11/257,927 US20070128685A1 (en) | 2005-07-01 | 2005-10-24 | Methods and compositions for cell culture |
US11/257,573 US20070004036A1 (en) | 2005-07-01 | 2005-10-24 | Methods and compositions for keratinocyte culture |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007005787A2 WO2007005787A2 (en) | 2007-01-11 |
WO2007005787A3 true WO2007005787A3 (en) | 2009-04-23 |
Family
ID=37605118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/025907 WO2007005787A2 (en) | 2005-07-01 | 2006-06-30 | Methods and compositions for keratinocyte culture and therapeutics |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007005787A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0613856D0 (en) * | 2006-07-13 | 2006-08-23 | Isis Innovation | Method for reducing spasms |
CN110358723A (en) * | 2019-05-08 | 2019-10-22 | 广州医科大学附属第二医院 | A kind of fibroblastic cultural method of adult mouse heart |
KR102560183B1 (en) * | 2021-02-09 | 2023-07-27 | 한국과학기술원 | Medium composition of cell culture for enhancing medical protein production and method of producing medical protein using the same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
-
2006
- 2006-06-30 WO PCT/US2006/025907 patent/WO2007005787A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
Non-Patent Citations (2)
Title |
---|
RILEY ET AL.: "Collagenase Promotes the Cellular Responses to Injury and Wound Healing In Vivo.", JOURNAL OF BUMS AND WOUNDS, vol. 4, May 2005 (2005-05-01), pages 112 - 124 * |
TEMPLETON ET AL.: "Cloning and Characterization of Human Tumor Interstitial Collagenase.", CANCER RESEARCH, vol. 50, September 1990 (1990-09-01), pages 5431 - 5437 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007005787A2 (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009006594A (en) | Formulations. | |
TW200618817A (en) | Diffractive colorants for cosmetics | |
WO2007097993A3 (en) | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor | |
RS50510B (en) | FORMULATIONS CONTAINING ECTEINASCIDINE AND DISAHARID | |
DE602005012276D1 (en) | USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE SKIN | |
PH12014502880A1 (en) | Lyophilized therapeutic peptibody formulations | |
TW200637490A (en) | Fertilizer-compatible composition | |
WO2008155659A3 (en) | Compositions for preventing or treating skin defects and methods of use thereof | |
EP1988159A4 (en) | Additive for culture medium for use in serum-free culture of animal cell, kit, and use of the additive or kit | |
TW200609888A (en) | Liquid crystal composition for bistable liquid crystal devices | |
TW200728285A (en) | Diacylindazole derivatives as inhibitors of lipases and phospholipases | |
IL198626A0 (en) | Core-1 positive microorganisms, compositions containing the same and methods of use thereof | |
EP1915440A4 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
WO2006093857A3 (en) | Method of providing readily available cellular material derived from peripheral blood and a composition thereof | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
WO2005082341A3 (en) | NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF | |
WO2007062243A3 (en) | Serum-free expansion of cells in culture | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
WO2006065861A3 (en) | Therapeutic formulations of keratinocyte growth factor | |
TW200736227A (en) | New compounds III | |
TW200734462A (en) | Regulating stem cells | |
WO2007028079A3 (en) | Methods of stimulating expansion of hematopoietic stem cells | |
HK1084409A1 (en) | Liquid composition for metachromatic members, and metachromatic member set making use of the same | |
NO20092073L (en) | C3A receptor modulators, and methods for their use | |
MX2007011381A (en) | Spirulin composition rich in active principles, method for obtaining same and use thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06774443 Country of ref document: EP Kind code of ref document: A2 |